Primary use context
- Frequently positioned as a general resilience or antioxidant ingredient.
- Human efficacy claims are broader than current trial support.
- Use only with clear rationale and periodic reassessment.
Medicinal fungus profile
Chaga (Inonotus obliquus)
Chaga is marketed for antioxidant wellness, while strong human efficacy evidence is limited and kidney safety deserves emphasis.
Explore fungi guides
Safety and interaction checkpoints
- Case reports link high intake to oxalate nephropathy and kidney injury.
- Use extra caution in kidney disease or stone-risk history.
- Avoid high-dose long-duration intake without clinician oversight.
Evidence interpretation
Evidence tier for this fungus: Low. Product form, extraction method, and quality testing can change real-world outcomes. Use clinician review for pregnancy, anticoagulants, glucose-lowering therapy, liver disease, kidney disease, and oncology care.